Avidity Biosciences

Avidity Biosciences

Biotechnology, Science Center Dr Ste 125, San Diego, , 92121, California, 10578, United States, 51-200 Employees

aviditybiosciences.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is AVIDITY BIOSCIENCES

DELIVERING ON OUR VISION Our vision is to profoundly improve peoples lives by revolutionizing the delivery of RNA therapeutics. Were utilizing our proprietary AOC platform to design, engi...

Read More

map
  • 10578 Science Center Dr Ste 125, San Diego, California, 92121, United States Headquarters: 10578 Science Center Dr Ste 125, San Diego, California, 92121, United States
  • 2013 Date Founded: 2013
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Sarah Boyce CEO:   Sarah Boyce

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AVIDITY BIOSCIENCES

Avidity Biosciences Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Avidity Biosciences

Answer: Avidity Biosciences's headquarters are located at Science Center Dr Ste 125, San Diego, , 92121, California, 10578, United States

Answer: Avidity Biosciences's phone number is 85********

Answer: Avidity Biosciences's official website is https://aviditybiosciences.com

Answer: Avidity Biosciences's revenue is $1 Million to $5 Million

Answer: Avidity Biosciences's SIC: 2834

Answer: Avidity Biosciences's NAICS: 325412

Answer: Avidity Biosciences has 51-200 employees

Answer: Avidity Biosciences is in Biotechnology

Answer: Avidity Biosciences contact info: Phone number: 85******** Website: https://aviditybiosciences.com

Answer: DELIVERING ON OUR VISION Our vision is to profoundly improve peoples lives by revolutionizing the delivery of RNA therapeutics. Were utilizing our proprietary AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) with the precision of oligonucleotide-based therapies in order to redefine RNA therapeutics and more effectively target underlying genetic drivers of diseases. We are delivering on this vision by investing in our platform, our pipeline and our people. Through this platform, we are pleased to share our ideas and company progress as we advance our science and overall mission to deliver breakthrough therapies to patients.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access